BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26188282)

  • 1. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma.
    Zhang H; Sheng C; Yin Y; Wen S; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2015 Oct; 367(1):49-57. PubMed ID: 26188282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
    Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGO2 Mediates
    Zhang K; Pomyen Y; Barry AE; Martin SP; Khatib S; Knight L; Forgues M; Dominguez DA; Parhar R; Shah AP; Bodzin AS; Wang XW; Dang H
    Mol Cancer Res; 2020 Apr; 18(4):612-622. PubMed ID: 31941754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing.
    Chen YL; Yuan RH; Yang WC; Hsu HC; Jeng YM
    J Pathol; 2013 Feb; 229(3):486-96. PubMed ID: 23097274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG14 promotes hepatocellular carcinoma progression via H3K27 acetylation activated PABPC1 by PTEN signaling.
    Zhang H; Xu HB; Kurban E; Luo HW
    Cell Death Dis; 2020 Aug; 11(8):646. PubMed ID: 32811821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
    Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
    PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma.
    Yang Y; Mei Q
    Biomed Res Int; 2020; 2020():1631843. PubMed ID: 32420319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.
    Cheng N; Li Y; Han ZG
    Hepatology; 2013 May; 57(5):1906-18. PubMed ID: 23258480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
    Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
    Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.
    Yuan JH; Liu XN; Wang TT; Pan W; Tao QF; Zhou WP; Wang F; Sun SH
    Nat Cell Biol; 2017 Jul; 19(7):820-832. PubMed ID: 28553938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC).
    Gao B; Gao K; Li L; Huang Z; Lin L
    Biomed Pharmacother; 2014 Mar; 68(2):143-8. PubMed ID: 24183204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
    Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
    Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer.
    Luna JM; Barajas JM; Teng KY; Sun HL; Moore MJ; Rice CM; Darnell RB; Ghoshal K
    Mol Cell; 2017 Aug; 67(3):400-410.e7. PubMed ID: 28735896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.